Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma

Hepatology

Volumn 59, Issue 3, 2014, Pages 935-946

  Zheng, Tongsen ^a   Hong, Xuehui ^a   Wang, Jiabei ^a   Pei, Tiemin ^a   Liang, Yingjian ^a   Yin, Dalong ^a   Song, Ruipeng ^a   Song, Xuan ^a   Lu, Zhaoyang ^a   Qi, Shuyi ^a   Liu, Jiaren ^b   Sun, Boshi ^a   Xie, Changming ^a   Pan, Shangha ^a   Li, Yuejin ^a   Luo, Xiaohe ^a   Li, Shuai ^a   Fang, Xiang ^a   Bhatta, Nishant ^a   Jiang, Hongchi ^a   Liu, Lianxin ^a   more..

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN E; GANKYRIN; GELATINASE A; GELATINASE B; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; RETINOBLASTOMA PROTEIN; SMALL INTERFERING RNA; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; G1 PHASE CELL CYCLE CHECKPOINT; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; OVERALL SURVIVAL; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR VOLUME;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL CYCLE CHECKPOINTS; CELL MOVEMENT; CHOLANGIOCARCINOMA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-6; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84896694682     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26705     Document Type: Article

References (36)

1. Chen Q, Li W, Wan Y, Xia X, Wu Q, Chen Y, et al. Amplified in breast cancer 1 enhances human cholangiocarcinoma growth and chemoresistance by simultaneous activation of Akt and Nrf2 pathways. Hepatology 2012;55:1820-1829.
2. Boland B, Kim A, Nissen N, Colquhoun S. Cholangiocarcinoma: aggressive surgical intervention remains justified. Am Surg 2012;78:157-160.
3. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet 2005;366:1303-1314.
4. Lau SH, Lau WY. Current therapy of hilar cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 2012;11:12-17.
5. Romiti A, D'Antonio C, Zullo A, Sarcina I, Di Rocco R, Barucca V, et al. Chemotherapy for the biliary tract cancers: moving toward improved survival time. J Gastrointest Cancer 2012;43:396-404.
6. Mayer RJ, Fujita J. Gankyrin, the 26 S proteasome, the cell cycle and cancer. Biochem Soc Trans 2006;34(Pt 5):746-748.
7. Higashitsuji H, Itoh K, Nagao T, Dawson S, Nonoguchi K, Kido T, et al. Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas. Nat Med 2000;6:96-99.
8. Fu XY, Wang HY, Tan L, Liu SQ, Cao HF, Wu MC. Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance. World J Gastroenterol 2002;8:638-643.
9. Umemura A, Itoh Y, Itoh K, Yamaguchi K, Nakajima T, Higashitsuji H, et al. Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma. Hepatology 2008;47:493-502.
10. Fu J, Chen Y, Cao J, Luo T, Qian YW, Yang W, et al. p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1α pathways. Hepatology 2011;53:181-192.
11. Sun W, Ding J, Wu K, Ning BF, Wen W, Sun HY, et al. Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells. Hepatology 2011;54:1259-1272.
12. Qian YW, Chen Y, Yang W, Fu J, Cao J, Ren YB, et al. p28(GANK) prevents degradation of Oct4 and promotes expansion of tumor-initiating cells in hepatocarcinogenesis. Gastroenterology 2012;142:1547-1558.
13. Tang S, Yang G, Meng Y, Du R, Li X, Fan R, et al. Overexpression of a novel gene gankyrin correlates with the malignant phenotype of colorectal cancer. Cancer Biol Ther 2010;9:88-95.
14. Meng Y, He L, Guo X, Tang S, Zhao X, Du R, et al. Gankyrin promotes the proliferation of human pancreatic cancer. Cancer Lett 2010;297:9-17.
15. Ortiz CM, Ito T, Tanaka E, Tsunoda S, Nagayama S, Sakai Y, et al. Gankyrin oncoprotein overexpression as a critical factor for tumor growth in human esophageal squamous cell carcinoma and its clinical significance. Int J Cancer 2008;122:325-332.
16. Zhen C, Chen L, Zhao Q, Liang B, Gu YX, Bai ZF, et al. Gankyrin promotes breast cancer cell metastasis by regulating Rac1 activity. Oncogene 2013;32:3452-3460.
17. Nakamura Y, Nakano K, Umehara T, Kimura M, Hayashizaki Y, Tanaka A, et al. Structure of the oncoprotein gankyrin in complex with S6 ATPase of the 26S proteasome. Structure 2007;15:179-189.
18. Dawson S, Apcher S, Mee M, Higashitsuji H, Baker R, Uhle S, et al. Gankyrin is an ankyrin-repeat oncoprotein that interacts with CDK4 kinase and the S6 ATPase of the 26 S proteasome. J Biol Chem 2002;277:10893-10902.
19. Zheng T, Meng X, Wang J, Chen X, Yin D, Liang Y, et al. PTEN- and p53-mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude mice. J Cell Biochem 2010;111:218-228.
20. Feng Z, Liu L, Zhang C, Zheng T, Wang J, Lin M, et al. Chronic restraint stress attenuates p53 function and promotes tumorigenesis. Proc Natl Acad Sci U S A 2012;109:7013-7018.
21. Itoh K, Yoshioka K, Akedo H, Uehata M, Ishizaki T, Narumiya S. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med 1999;5:221-225.
22. Fava G, Alpini G, Rychlicki C, Saccomanno S, DeMorrow S, Trozzi L, et al. Leptin enhances cholangiocarcinoma cell growth. Cancer Res 2008;68:6752-6761.
23. Dunkel Y, Ong A, Notani D, Mittal Y, Lam M, Mi X, et al. STAT3 protein up-regulates Gα-interacting vesicle-associated protein (GIV)/Girdin expression, and GIV enhances STAT3 activation in a positive feedback loop during wound healing and tumor invasion/metastasis. J Biol Chem 2012;287:41667-41683.
24. Zhao Y, Zhang J, Xia H, Zhang B, Jiang T, Wang J, et al. Stat3 is involved in the motility, metastasis and prognosis in lingual squamous cell carcinoma. Cell Biochem Funct 2012;30:340-346.
25. Dawson S, Higashitsuji H, Wilkinson AJ, Fujita J, Mayer RJ. Gankyrin: a new oncoprotein and regulator of pRb and p53. Trends Cell Biol 2006;16:229-233.
26. Santhanam U, Ray A, Sehgal PB. Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc Natl Acad Sci U S A 1991;88:7605-7509.
27. Sehgal PB. Regulation of IL6 gene expression. Res Immunol 1992;143:724-734.
28. Frampton G, Invernizzi P, Bernuzzi F, Pae HY, Quinn M, Horvat D, et al. Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism. Gut 2012;61:268-277.
29. Braconi C, Swenson E, Kogure T, Huang N, Patel T. Targeting the IL-6 dependent phenotype can identify novel therapies for cholangiocarcinoma. PLoS One 2010;5:e15195.
30. Wehbe H, Henson R, Meng F, Mize-Berge J, Patel T. Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression. Cancer Res 2006;66:10517-10524.
31. Jiang Y, Iakova P, Jin J, Sullivan E, Sharin V, Hong IH, et al. Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer. Hepatology 2013;57:1098-1106.
32. Mine H, Sakurai T, Kashida H, Matsui S, Nishida N, Nagai T, et al. Association of gankyrin and Stemness Factor Expression in Human Colorectal Cancer. Dig Dis Sci 2013;58:2337-2344.
33. Liu Y, Higashitsuji H, Higashitsuji H, Itoh K, Sakurai T, Koike K, et al. Overexpression of gankyrin in mouse hepatocytes induces hemangioma by suppressing factor inhibiting hypoxia-inducible factor-1 (FIH-1) and activating hypoxia-inducible factor-1. Biochem Biophys Res Commun 2013;432:22-27.
34. Lukashchuk N, Vousden KH. Ubiquitination and degradation of mutant p53. Mol Cell Biol 2007;27:8284-8285.
35. Zheng T, Wang J, Chen X, Meng X, Song X, Lu Z, Jiang H, et al. Disruption of p73-MDM2 binding synergizes with gemcitabine to induce apoptosis in HuCCT1 cholangiocarcinoma cell line with p53 mutation. Tumour Biol 2010;31:287-295.
36. Bai Z, Tai Y, Li W, Zhen C, Gu W, Jian Z, et al. Gankyrin activates IL-8 to promote hepatic metastasis of colorectal cancer. Cancer Res 2013;73:4548-4558.